A Comprehensive Review on Molecular Mechanism of HIF-1 alpha Pathway in Breast Cancer
Year: 2026
Type: article
Abstract: Breast cancer is one of the most prevalent malignancies worldwide, characterized by uncontrolled cell proliferation, angiogenesis, invasion, and metastasis. Tumor hypoxia contributes significantly to breast cancer progression through the activation of hypoxia-inducible factor-1 alpha (HIF-1α), which regulates cellular adaptation to low oxygen conditions. This review highlights the molecular mechanisms of HIF-1α signaling and its involvement in tumor progression, angiogenesis, metastasis, and therapeutic resistance. Conventional treatment strategies, including chemotherapy, radiotherapy, and hormone therapy, are discussed alongside emerging peptide-based therapeutic approaches. Particular attention is given to peptide-based hormone therapy, receptor-targeted peptides, peptide receptor radionuclide therapy, peptide vaccines, anticancer peptides, and peptide-mediated drug delivery. Key molecular targets, including epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), and HIF-1α, are examined. The review further explores hypoxia-associated metabolic adaptations, transcriptional regulation, apoptosis, cell proliferation, and tumor survival pathways. Molecular docking is highlighted as a promising approach for identifying potential anticancer therapeutic candidates. Additionally, advanced peptide delivery systems involving cell-penetrating peptides, chitosan, sodium alginate, biocompatible polymers, and nanoparticles are discussed for improving targeted delivery and therapeutic efficacy. Animal models are also considered for evaluating treatment strategies. Overall, integrating HIF-1α-targeted interventions with peptide-based drug delivery may offer promising opportunities for developing innovative breast cancer therapies.
Institutions: Periyar University, KS Rangasamy College of Arts and Science
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Keywords: breast cancer, HIF-1α, tumor hypoxia, angiogenesis, metastasis, treatment resistance, peptide-based drug delivery, peptide receptor radionuclide therapy, peptide vaccine, anticancer peptides, EGFR, vascular endothelial growth factor, apoptosis, cell proliferation, molecular docking, cell-penetrating peptides, chitosan, sodium alginate, biocompatible polymers, nanoparticles, animal models
Open Access status: hybrid
OpenAlex ID: W7234235097
